Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | AZN | AMGN | GILD | VRTX |
| Company | Akero Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 54.52 | 94.14 | 327.42 | 122.59 | 460.22 |
| High | 54.83 | 94.54 | 327.75 | 123.81 | 462.42 |
| Low | 54.37 | 92.78 | 319.79 | 120.22 | 452.91 |
| Latest | 54.65 | 94.51 | 324.30 | 121.76 | 454.67 |
| Change | +0.10 | +0.88 | -1.24 | -0.84 | -5.92 |
| % Change | +0.18% | +0.94% | -0.38% | -0.69% | -1.29% |
| Volume | 15,312,200 | 8,037,200 | 2,382,200 | 5,803,800 | 1,346,100 |
| 20-Day Average Volume | 2,420,955 | 5,142,935 | 2,783,475 | 6,416,970 | 1,351,250 |
| Previous Close | 54.55 | 93.63 | 325.54 | 122.60 | 460.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 54.38 | 92.52 | 328.57 | 122.40 | 458.92 |
| 20-Day Raw Stochastic | 78.26% | 71.35% | 24.52% | 46.34% | 26.01% |
| 20-Day Relative Strength | 65.57 | 60.50 | 48.91 | 49.21 | 52.22 |
| Weighted Alpha | +16.80 | +44.67 | +18.96 | +27.64 | +8.62 |
| Today's Opinion | 100% Buy | 100% Buy | 48% Buy | 40% Buy | 64% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 88% Buy | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.39% since 12/01/25 | -0.47% since 01/06/26 | -1.78% since 01/06/26 | +0.33% since 01/06/26 | -2.93% since 01/06/26 |
| Low | 54.29 on 12/05/25 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 452.91 on 01/13/26 |
| High | 54.83 on 12/08/25 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 125.11 on 01/08/26 | 487.52 on 01/07/26 |
| 1-Month | |||||
| %Chg | +1.13% since 11/07/25 | +5.21% since 12/12/25 | +2.06% since 12/12/25 | +1.13% since 12/12/25 | +0.58% since 12/12/25 |
| Low | 54.02 on 11/10/25 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 443.12 on 01/05/26 |
| High | 54.83 on 12/08/25 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +22.62% since 09/08/25 | +11.83% since 10/13/25 | +10.91% since 10/13/25 | +3.00% since 10/13/25 | +11.61% since 10/13/25 |
| Low | 41.77 on 09/15/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 54.83 on 12/08/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +0.68% since 06/06/25 | +32.87% since 07/11/25 | +9.83% since 07/11/25 | +11.05% since 07/11/25 | -3.02% since 07/11/25 |
| Low | 41.77 on 09/15/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 57.35 on 06/27/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,499,006 | 293,118,208 | 174,629,376 | 151,065,216 | 115,358,416 |
| Shares Outstanding, K | 82,324 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -252,060,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -81,570,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -0.40 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 11/07/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/27/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.49 | 14.89 | 14.97 | 30.08 |